N
CNST

Nuveen’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Nuveen’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-119,496
Closed -$2.42M – 3482
2021
Q2 		$2.42M Buy
119,496
+12,374
+12% +$315K ﹤0.01% 2614
2021
Q1 		$2.51M Sell
107,122
-50,059
-32% -$1.52M ﹤0.01% 2513
2020
Q4 		$4.53M Sell
157,181
-22,194
-12% -$559K ﹤0.01% 2129
2020
Q3 		$3.63M Buy
179,375
+36,495
+26% +$891K ﹤0.01% 2087
2020
Q2 		$4.29M Buy
142,880
+56,883
+66% +$2.05M ﹤0.01% 1980
2020
Q1 		$2.7M Buy
85,997
+15,521
+22% +$540K ﹤0.01% 2040
2019
Q4 		$3.32M Buy
70,476
+29,426
+72% +$850K ﹤0.01% 2203
2019
Q3 		$265K Hold
41,050
– – ﹤0.01% 3069
2019
Q2 		$504K Buy
+41,050
New +$457K ﹤0.01% 3006

Nuveen's CNST Position: Q3 2021 in Review

Nuveen sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 119,496 shares — an estimated $2.42M sold.

Nuveen first reported a position in CNST in Q2 2019 and held it in 9 quarters. The position peaked at $4.53M in Q4 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Nuveen reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Nuveen sold 119,496 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.42M.
  • Nuveen first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2019 and held it in 9 quarters.
  • Nuveen's Constellation Pharmaceuticals, Inc. position peaked at $4.53M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Nuveen's 13F filing for Q3 2021, filed 12 Nov 2021.